Related Experiment Videos
Plasma exchange in systemic lupus erythematosus
Annals of the Rheumatic Diseases
|June 1, 1981
Summary
Plasmapheresis provided short-term benefits for eight of 10 patients with systemic lupus erythematosus. However, plasma exchange alone is not recommended for long-term management, suggesting its value in combination therapy.
Area of Science:
- Immunology
- Rheumatology
- Nephrology
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
- Plasmapheresis is a therapeutic apheresis technique used in various autoimmune conditions.
- The role of plasmapheresis in SLE management requires further elucidation.
Purpose of the Study:
- To evaluate the efficacy of plasmapheresis in patients with systemic lupus erythematosus.
- To assess the longitudinal benefit of plasmapheresis in SLE patients.
- To determine the correlation between circulating immune complexes and clinical outcomes.
Main Methods:
- Longitudinal study design with patients serving as their own controls.
- Application of plasmapheresis as a therapeutic intervention.
- Monitoring of clinical status and levels of circulating immune complexes.
Main Results:
- Eight out of ten patients demonstrated clinical improvement with plasmapheresis.
- Circulating immune complex levels did not consistently correlate with clinical response.
- Plasma exchange alone did not show significant long-term disease modification.
Conclusions:
- Plasmapheresis may offer temporary benefit in SLE management.
- The combination of plasmapheresis with other therapies warrants investigation.
- Further research is needed to define the optimal role of plasmapheresis in SLE treatment protocols.